PMC:7170368 / 573-737 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":135,"end":139},"obj":"Gene"},{"id":"22","span":{"begin":24,"end":32},"obj":"Species"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Gene:3569"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":154,"end":159},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":154,"end":159},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":51,"end":54},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0012733"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":67,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":103,"end":104},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":118,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5","span":{"begin":154,"end":159},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T6","span":{"begin":154,"end":159},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19","span":{"begin":135,"end":137},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A20","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":7,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"itors. We observed that patients receiving ACEI or ARB therapy had a lower rate of severe diseases and a trend toward a lower level of IL-6 in peripheral blood. In "}